English name | Zolmitriptan 佐米曲普坦 |
Synonyms | (4r)-4-[[3-(2-dimethylaminoethyl)-1h-indol-5-yl]methyl]oxazolidin-2-one;Zolmitriptan;AssistsMiQuPuTanzania;Zolmitriptan(Chemicalbook150mg);(4R)-4-({3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl}Methyl)-1,3-oxazolidin-2-one;ZolMitriptan(ZoMig);ZolMitriptanAPI |
CAS | 139264-17-8 |
EINECS | 629-919-0 |
Molecular formula | C16H21N3O2 |
Molecular weight | 287.36 |
Chemical formula |
|
Content > | |
Density | 1.217±0.06 g/cm3(Predicted) |
Melting point | 136-141°C |
Specific rotation | D22 -5.79° (c = 0.5 in methanol) |
Boiling point | 563.3±38.0 °C(Predicted) |
Solubility | Soluble in DMSO at 5mg/ml |
Acidity coefficient | 9.64(at 25℃) |
λmax | 225nm(lit.) |
Storage condition | 15-25°C |
Appearance | powder |
Colour | white to beige |
optical activity | [α]/D -3 to -8°, c = 1 in methanol |
Merck | 14,10189 |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
InChIKey | ULSDMUVEXKOYBU-ZDUSSCGKSA-N |
HS | 29349990 |
Use | For the acute treatment of migraine with or without aura symptoms. |
Dangerous mark | Xi,Xn |
Risk phrases | 36/37/38-22 |
Safety phrases | 26-36 |
WGK Germany | 3 |
Hazard Note | women,TDLo,oral,6mg/kg/43W-I (6mg/kg),BEHAVIORAL: HEADACHE,Lancet. Vol. 353, Pg. 378, 1999. |
RTECS | RQ2707000 |
Upstream raw materials | COPPER(II) OXIDE dimethylamine quinoline 6-dimethylaminopurine methylsulfonate |
